Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area – Post-Market Clinical Follow-up (SEPTA PMCF)

The goal of this observational post-market clinical Follow-up study is to learn about the long-term safety, performance, and clinical benefits of pacing the left bundle branch area (LBBAP) using the INGEVITY+ pacemaker lead in patients with bradycardia who need a pacemaker

ClinicalTrials.gov ID: NCT07209852

Sponsor: Boston Scientific Corporation

ClinicalTrials.gov link for more information

The goal of this observational post-market clinical Follow-up study is to learn about the long-term safety, performance, and clinical benefits of pacing the left bundle branch area (LBBAP) using the INGEVITY+ pacemaker lead in patients with bradycardia who need a pacemaker

ClinicalTrials.gov ID: NCT07209852

Sponsor: Boston Scientific Corporation

ClinicalTrials.gov link for more information